Dr. Axel Bouchon serves as Head of Bayer Life Science Center of Bayer HealthCare AG. Dr. Bouchon has been Head of Global Business Development & Licensing at Bayer HealthCare since April 1, 2015. He has temporarily assumed these duties in addition to his current assignment as Head of the LifeScience Center of Bayer AG. He began his career in industry at Cytos Biotechnology AG in Z ¼rich. In 2002, he transferred to Bayer AG as a laboratory manager at the Pharmaceutical Research Center in Wuppertal. From 2007, he was also active in Mergers & Acquisitions for Bayer HealthCare's Pharmaceuticals Division. In 2010 he moved to Singapore as Head of Pharmaceuticals and was then Country Division Head for the Bayer HealthCare subregion Singapore, Malaysia and Brunei. In 2012, he returned to Germany where he was responsible for Strategic Planning at Bayer HealthCare. Before taking over as Head of the LifeScience Center of Bayer AG effective January 1, 2015, he was Senior Vice President of the U.S. company Moderna Therapeutics, Inc. He also founded, financed and managed various start-up companies focusing on human, animal and plant diseases on the basis of the Moderna technology platform. In 1998, he received his degree in biochemistry, organic chemistry and immunology “ with a diploma thesis that he wrote at the German Cancer Research Center â “ from Eberhard Karls University in Tübingen / Germany. He earned his doctorate (Dr. rer. nat.) from Tübingen in 2002 with a thesis that he executed at the Basel Institute for Immunology of Roche AG.

Research, Pharmaceuticals, Biotechnology, Healthcare, Medical Science